Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Hongjie Xing und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, P. R. China. Hauptthemen laut MEDLINE: Tigecycline, Staphylococcus aureus, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Outstanding Foreign Scientist Studio in Henan province.
Abstract (Originalsprache)
Objectives
To identify the role and function of mepR variants in conferring resistance to tigecycline in clinical Staphylococcus aureus.
Methods
The identification of the mepR and mepA variants in S. aureus DMB26a was performed by whole-genome sequencing and Blast alignment. The effects of the mepRD and mepAD variants of DMB26a on tigecycline susceptibility were evaluated through deletion and complementation analyses, as well as the determination of gene expression levels by RT-qPCR. Minimal inhibitory concentrations (MICs) for DMB26a and its mutants were determined by antimicrobial susceptibility testing.
Results
A mepR variant, designated mepRD, and a mepA variant, designated mepAD, were identified in the clinical tigecycline-resistant S. aureus isolate DMB26a, which showed 78.72% and 84.92% amino acid identity to the MepR and MepA proteins of S. aureus NCTC 8325-4, respectively. Our findings revealed that deletion of mepA in the tigecycline-susceptible S. aureus RN4220 did not lead to a decrease in the MIC of tigecycline, and that there was also no change in the tigecycline MIC after the complementation with mepAD. Furthermore, we constructed a mepR + mepA deletion strain of S. aureus RN4220 and complemented it with mepRD + mepAD. In that case, a 4-fold increase in the tigecycline MIC was observed in S. aureus RN4220ΔmepR + mepA-pLI50_mepRD + mepAD compared with S. aureus RN4220ΔmepR + mepA. In addition, the relative expression of mepAD was increased 6-fold under the regulation of mepRD.
Conclusions
This study provides the identification of a mepR variant contributing indirectly to tigecycline resistance via mediating increased expression of mepA in a clinical S. aureus isolate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, P. R. China.
- Institute of Microbiology and Epizootics, Centre for Infection Medicine, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
- Veterinary Centre of Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.
ORCID-Profile: Stefan Schwarz, Xiang-Dang Du
Förderung
- National Natural Science Foundation of China
- Outstanding Foreign Scientist Studio in Henan province
Zitieren
APA
Xing, H., Zhang, L., Li, C., Schwarz, S., Li, D., & Du, X. D. (2025). Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf034
Vancouver
Xing H, Zhang L, Li C, Schwarz S, Li D, Du XD. Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf034
BibTeX
@article{Xing2025,
author = {Xing, Hongjie and Zhang, Likuan and Li, Chenglong and Schwarz, Stefan and Li, Dexi and Du, Xiang-Dang},
title = {Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf034}
}
EUVIMED